Inhibition of T-Cell activation by the CTLA4-Fc abatacept is sufficient to ameliorate proteinuric kidney disease
- Herrera, M.
- Söderberg, M.
- Sabirsh, A.
- Valastro, B.
- Mölne, J.
- Santamaria, B.
- Valverde, A.M.
- Guionaud, S.
- Heasman, S.
- Bigley, A.
- Jermutus, L.
- Rondinone, C.
- Coghlan, M.
- Baker, D.
- Quinn, C.M.
ISSN: 1522-1466, 0363-6127
Year of publication: 2017
Volume: 312
Issue: 4
Pages: F748-F759
Type: Article